Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 35 for “"Aggressive B-cell"”.

  1. Immunogenetic analysis of aggressive B-cell malignancies

    <p>Normal B cells undergo a series of recombinatorial and mutational changes during differentiation that lead to unique sequences in the immunoglobulin (Ig) heavy and light chain variable (V) region genes. The defining event is the rearrangement of the heavy and light chain genes in the bone marrow …

    soton Download PDF for Immunogenetic analysis of aggressive B-cell malignancies (opens in a new tab)

  2. Epigenetic-mediated apoptosis in aggressive B-cell lymphomas

    … group of cancers arising from mature lymphoid cells. Despite advances in the treatment and management of this disease, it remains a health challenge as response to treatment and survival outcomes differ in various lymphoma subtypes. The exact causes driving lymphomagenesis remain unknown, and …

    fu-berlin Repository record for Epigenetic-mediated apoptosis in aggressive B-cell lymphomas (opens in a new tab)

  3. Environmental stress-related ‘stem-ness’ in aggressive B-cell lymphoma

    … The tumour microenvironment is stressful for cells. Hypoxia and nutrient deprivation occur as the tumour develops and cells compete for oxygen, nutrients and space. Such cell stresses may be associated with the development of cancer stem cells (CSCs). CSCs are capable of self-renewal and …

    edinburgh Repository record for Environmental stress-related ‘stem-ness’ in aggressive B-cell lymphoma (opens in a new tab)

  4. Zebrafish modelling of apoptosis and inflammation in aggressive B-cell lymphoma

    Apoptosis is a well-orchestrated programmed cell death. In cancer biology the evasion of apoptosis has been considered as one of the key events for tumour development and paradoxically, studies also show that apoptosis has detrimental effects that may even promote cancer. High rates of apoptosis …

    edinburgh Repository record for Zebrafish modelling of apoptosis and inflammation in aggressive B-cell lymphoma (opens in a new tab)

  5. PDL1-Expressing Macrophages as Drivers of Immune Suppression in Aggressive B-Cell Lymphoma

    Aggressive B-cell lymphomas are shaped not only by tumor-intrinsic alterations but by the composition and structure of their immune microenvironment. The central aim of this thesis was to define how immune architecture varies across lymphoma entities and clinical contexts, and to determine how …

    zurich

  6. Integrating molecular approaches to advance the diagnostic and therapeutic framework of aggressive B-cell lymphomas

    Aggressive B-cell lymphomas encompass a heterogeneous group of neoplasms unified by their rapid clinical course and potential for cure with appropriate therapy. Traditional classification systems, grounded in morphology, often fail to capture the molecular diversity that shapes prognosis and …

    ubc Repository record for Integrating molecular approaches to advance the diagnostic and therapeutic framework of aggressive B-cell lymphomas (opens in a new tab) Download PDF for Integrating molecular approaches to advance the diagnostic and therapeutic framework of aggressive B-cell lymphomas (opens in a new tab)

  7. Identification and characterization of pathogenetically relevant genes in mature aggressive B-cell lymphomas of childhood by a combination of genomic and functional analyses

    … (BL) account for about 25 % of the mature B-cell lymphomas in childhood. The hallmark of BL is the chromosomal translocation t(8;14)(q24;q32), juxtaposing the MYC gene to the immunoglobulin (IG) heavy chain locus, or one of its light chain variants. These translocations result in …

    cau-kiel Repository record for Identification and characterization of pathogenetically relevant genes in mature aggressive B-cell lymphomas of childhood by a combination of genomic and functional analyses (opens in a new tab)

  8. Clinical comparison of the efficacy and toxicity of axicabtagene ciloleucel and lisocabtagene maraleucel in relapsed or refractory aggressive B-cell non-Hodgkin's lymphoma

    … Patients with relapsed or refractory large B-cell lymphoma (LBCL) who have relapsed after at least 2 lines of therapy had a poor prognosis before the introduction of chimeric antigen receptor (CAR) T-cell therapy. The FDA approved three CD19 CAR T-cell products, axicabtagene ciloleucel …

    bu Repository record for Clinical comparison of the efficacy and toxicity of axicabtagene ciloleucel and lisocabtagene maraleucel in relapsed or refractory aggressive B-cell non-Hodgkin's lymphoma (opens in a new tab)

  9. Analysis of the Potential Cost Utility of the Addition of Rituximab to Standard Chemotherapy in Adults with Aggressive B Cell Non-Hodgkin Lymphoma in Uganda

    … that confers a survival benefit in adults with aggressive B cell Non-Hodgkin Lymphoma (B-NHL), and has been shown to be cost-effective in in high-income settings. Rituximab is not widely available in Uganda and other low-income countries due to cost. This is an evaluation of the potential …

    washington Repository record for Analysis of the Potential Cost Utility of the Addition of Rituximab to Standard Chemotherapy in Adults with Aggressive B Cell Non-Hodgkin Lymphoma in Uganda (opens in a new tab)

  10. Early clinical and radiological predictors of relapse following partial response to chimeric antigen receptor T-cell therapy in patients with aggressive B-cell Non-Hodgkins lymphoma

    INTRODUCTION: Chimeric antigen receptor (CAR) T-cell therapy is a relatively new cancer immunotherapy that is offering remarkable benefits for patients in the third line setting for relapsed/refractory aggressive large B-cell non-Hodgkin’s lymphoma (NHL). At one-month restaging post CAR T-cell …

    bu Repository record for Early clinical and radiological predictors of relapse following partial response to chimeric antigen receptor T-cell therapy in patients with aggressive B-cell Non-Hodgkins lymphoma (opens in a new tab)

  11. Patient and disease precursors and clinical predictors of prolonged cytopenias in patients with aggressive B-cell non-Hodgkin's lymphoma treated with chimeric antigen receptor T-cell therapy

    INTRODUCTION: Chimeric antigen receptor (CAR) T-cell therapy is a new treatment for hematologic malignancies including aggressive B-cell non-Hodgkin’s lymphoma (NHL). Although it has provided an effective treatment option for patients who have few options, CAR T-cell therapy does have many …

    bu Repository record for Patient and disease precursors and clinical predictors of prolonged cytopenias in patients with aggressive B-cell non-Hodgkin's lymphoma treated with chimeric antigen receptor T-cell therapy (opens in a new tab)

  12. DISSECTING THE ROLE OF SETD2 IN GERMINAL CENTER DEVELOPMENT AND LYMPHOMAGENESIS

    … is highly expressed in germinal center B cells, mature B cell lymphomas and is recurrently mutated in DLBCL. We found that SETD2 haploinsufficiency results in germinal center hyperplasia and defective plasma cell differentiation following antigen stimulation. This was caused by decreased …

    cornell Repository record for DISSECTING THE ROLE OF SETD2 IN GERMINAL CENTER DEVELOPMENT AND LYMPHOMAGENESIS (opens in a new tab)

  13. Gene expression profiling and immunoglobulin stereotypy in Burkitt lymphoma

    … chapter of this thesis presents two improved aggressive B cell lymphoma classifiers based on a novel technology that does not require material amplification, avoiding quantification bias. In chapter two the former classifier is used to understand molecular labelling differences between …

    cau-kiel Repository record for Gene expression profiling and immunoglobulin stereotypy in Burkitt lymphoma (opens in a new tab)

  14. MYC/MIZ1 complex formation is essential in development of aggressive Germinal Center-derived lymphomas

    … be critically required in germinal center (GC) B cell expansion. Both MYC and MIZ1 are transcriptional activators but their interaction can form a transcriptional repressor complex that suppresses MIZ1 target genes. Aggressive B cell lymphomas are mainly derived from GC B cells and high MYC …

    kings Repository record for MYC/MIZ1 complex formation is essential in development of aggressive Germinal Center-derived lymphomas (opens in a new tab) Download PDF for MYC/MIZ1 complex formation is essential in development of aggressive Germinal Center-derived lymphomas (opens in a new tab)

  15. Characterization of programmed death ligands in B-cell non-Hodgkin lymphomas

    … that originate from a population of white blood cells termed lymphocytes. Lymphoid cancers are a significant health burden in Canada, with over 9,200 new diagnoses in 2018. Of those newly diagnosed, roughly 40% will die within five years. Studying a subpopulation of aggressive B-cell derived …

    ubc Repository record for Characterization of programmed death ligands in B-cell non-Hodgkin lymphomas (opens in a new tab) Download PDF for Characterization of programmed death ligands in B-cell non-Hodgkin lymphomas (opens in a new tab)

  16. Differential Pax5 Levels Promote Mcl Dispersal and Progression and Predict A Poor Prognosis In Advanced Mcl Patients

    … PAX5 conditional silencing in mice models led to aggressive lymphoma formation, there has been a lack of understanding in the precise functions of PAX5 in human B cell cancers. PAX5 expression is used to diagnose different B cell lymphoma in the clinic including mantle cell lymphoma (MCL), which …

    uthsc Repository record for Differential Pax5 Levels Promote Mcl Dispersal and Progression and Predict A Poor Prognosis In Advanced Mcl Patients (opens in a new tab)

  17. A bioinformatic pipeline for integration of low and high dimensional multiomic datasets

    … with a risk of transforming into a more aggressive B-cell disease. Although recurrent mutations in FL are informative of transformation risk, biological predictors of transformation at diagnosis remain elusive. A previous study from our laboratory identified 2 phenotypic variation …

    ubc Repository record for A bioinformatic pipeline for integration of low and high dimensional multiomic datasets (opens in a new tab) Download PDF for A bioinformatic pipeline for integration of low and high dimensional multiomic datasets (opens in a new tab)

  18. Sequentielle Gabe von Hochdosismethotrexat- und Hochdosiscytarabin-basierter Polychemotherapie bei älteren Patienten mit primärem ZNS-Lymphom

    … Primary CNS lymphoma (PCNSL) is a rare and aggressive lymphoma subtype confined to the CNS at time of diagnosis. Age is the most important prognostic factor in PCNSL. No standard therapy has been established for elderly PCNSL patients. Here, we present an analysis of a sequential …

    fu-berlin Repository record for Sequentielle Gabe von Hochdosismethotrexat- und Hochdosiscytarabin-basierter Polychemotherapie bei älteren Patienten mit primärem ZNS-Lymphom (opens in a new tab)

Page 1 of 2